The International journal of pharmacy practice · 2026
The impact of policy changes on the sales of the environmentally harmful drug diclofenac in Sweden.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ljungberg Persson Christina, Aronsson Sebastian, Håkonsen Helle
Аннотация
OBJECTIVES: In Sweden, oral formulations of diclofenac became prescription-only in 2020, and over the counter (OTC) topical forms were placed behind the counter in 2023. This study investigated the effect of these policy changes on diclofenac dispensed or sold.
METHODS: Aggregated data on diclofenac dispensed against prescription or sold OTC from January 2019 to February 2024 were analysed descriptively.
KEY FINDINGS: The volume fell substantially after oral formulations became prescription-only. Placement of topical formulations behind the counter had a more modest effect.
CONCLUSIONS: Policy changes have had a significant effect on the volume of diclofenac dispensed or sold in Sweden, especially the prescription requirement.
METHODS: Aggregated data on diclofenac dispensed against prescription or sold OTC from January 2019 to February 2024 were analysed descriptively.
KEY FINDINGS: The volume fell substantially after oral formulations became prescription-only. Placement of topical formulations behind the counter had a more modest effect.
CONCLUSIONS: Policy changes have had a significant effect on the volume of diclofenac dispensed or sold in Sweden, especially the prescription requirement.